An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).
The results are published in The Lancet and have been presented at the EuroPCR congress in Paris.
If the findings are confirmed in more extensive clinical trials, the surgery could offer hope to patients with high blood pressure who do not respond to drugs, and are at increased risk of cardiovascular diseases, including stroke and heart attack.
The international clinical trial, carried out from 2017 to 2018 at St Bartholomew’s Hospital in the UK by the NIHRBarts Biomedical Research Centre, tested a one-hour operation called ‘renal denervation’, which uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry signals for controlling blood pressure.
Significant reduction in blood pressure
146 patients in the United States, France, Germany, the Netherlands, Belgium and the United Kingdom were randomised to receive either renal denervation or a ‘sham procedure’ – the surgical equivalent of a placebo. Patients also remained off blood pressure medications for two months unless specified blood pressure levels were exceeded.
After two months, the renal denervation group experienced an 8.5 mm Hg reduction in blood pressure, which was a 6.3 mm Hg greater reduction compared with the sham group.
More than 66 per cent of subjects treated with renal denervation demonstrated a 5 mm Hg or greater reduction in blood pressure, compared with 33 per cent in the sham group.
No major adverse events were reported in either group, and the blood pressure lowering effect of renal denervation was consistent across sex and ethnicity.
An alternative to lifelong medications
UK Principal Investigator Dr Melvin Lobo from Queen Mary’s William Harvey Research Institute and Barts Health NHS Trust said: “These results leave us clinicians in no doubt that this ultrasound-based therapy works to improve blood pressure control – at least in the short term. Further larger trials will be needed to confirm the efficacy and safety of the technology, but we hope that they could lead to renal denervation therapy being offered as an alternative to lifelong medications for hypertension.”
The study has limitations including the short follow-up time of two months. This was done for safety reasons to minimise the duration of patients being off antihypertensive medications. Longer follow-up of this trial and additional numbers of treated patients will be necessary to provide greater assurance of safety and to exclude rare adverse events.
Learn more: Surgery involving ultrasound energy found to treat high blood pressure
The Latest on: Hypertension
[google_news title=”” keyword=”hypertension” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hypertension
- Hypertensive Heart Disease: Cardiologist Explains Why These 6 Lifestyle Changes Are Important For Hypertension Patientson May 9, 2024 at 8:26 am
According to Dr. Santosh Kumar Dora, "Hypertensive heart disease often develops stealthily, without presenting obvious symptoms." Read on to know the steps you can take to alleviate the disease ...
- Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertensionon May 9, 2024 at 5:11 am
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – ...
- Pediatric hypertension associated with long-term cardiovascular events: JAMAon May 8, 2024 at 6:00 pm
A recent study from Ontario, Canada illuminated the long-term risks associated with childhood hypertension. This comprehensive study underlines the pressing need for increased awareness ...
- Exercise-Induced Hypertension a Risk Factor for Sudden Cardiac Death, Review Findson May 8, 2024 at 2:56 pm
A new review suggests exercise-induced hypertension (EIH) is a risk factor for sudden cardiac death (SCD), but that there are steps physicians and patients can take to lower the risk. The review was ...
- Rhode Island doctor highlights impacts of uncontrolled severe hypertensionon May 8, 2024 at 10:49 am
"It is known that only about one out of four adults with hypertension have it under control," said Dr. Junyang Lou.
- Pulmonary hypertension: Dietary changes may help with treatment, study findson May 8, 2024 at 8:06 am
Researchers say dietary changes that limit the amino acids glutamine and serine may help slow disease progression in pulmonary hypertension and improve the effectiveness of current medications.
- New treatment for pulmonary hypertension: what biotech holds in store?on May 8, 2024 at 6:00 am
While it has been about managing pulmonary hypertension's symptoms for a long time, new treatments are adressing the root of the disease.
- Novel Genetic Loci ID'd for Hypertension in European Ancestryon May 7, 2024 at 11:52 am
In an independent dataset, clinically meaningful differences in BP were seen when comparing top versus bottom deciles of polygenic risk scores (16.9 mm Hg systolic BP), and the odds of hypertension ...
- Long-Term Risk for MACE Increased for Children With Hypertensionon May 7, 2024 at 8:04 am
The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May 6 in JAMA Pediatrics to coincide with the ...
via Bing News